The Management of Native Vertebral Osteomyelitis Remains Unchanged: Are Additional Trials Necessary?

Werner Zimmerli

Open source

DOI
10.1093/cid/ciag049
Published
2026-02-04
Container
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag049,
  title = {The Management of Native Vertebral Osteomyelitis Remains Unchanged: Are Additional Trials Necessary?},
  author = {Werner Zimmerli},
  year = {2026},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciag049},
  url = {https://doi.org/10.1093/cid/ciag049}
}

RIS

TY  - JOUR
TI  - The Management of Native Vertebral Osteomyelitis Remains Unchanged: Are Additional Trials Necessary?
AU  - Werner Zimmerli
PY  - 2026
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciag049
UR  - https://doi.org/10.1093/cid/ciag049
ER  - 

APA

Zimmerli, W. (2026). The Management of Native Vertebral Osteomyelitis Remains Unchanged: Are Additional Trials Necessary?. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag049

Source records